Kush Parmar
CIK 1664281 · Co-CEO · last filed 2026-09-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
APRE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
4 EMBARCADERO CENTER, SUITE 3110
SAN FRANCISCO, CA 94111
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYE | 10%+ Owner | 114,851 | $1.53 | $175.7K | -$2.43M | 2 | 2026-09-24 |
| TRDA | Director | 1,093,313 | $4.67 | $5.10M | $284.8K | 12 | 2026-08-10 |
| RLYB | Director | 297,371 | $16.01 | $4.76M | $1.26M | 11 | 2024-05-17 |
| Akouos, Inc. (AKUS) Delisted | Director | 0 | $13.29 | $0 | -$3.46M | 5 | 2022-12-02 |
| FIXX | Director | 241,916 | $7.24 | $1.75M | -$37.36M | 13 | 2022-06-17 |
| VOR | Director | 88,332 | $18.31 | $1.62M | $4.94M | 3 | 2022-06-16 |
| 5:01 Acquisition Corp. (FVAM) Delisted | Co-CEO | 365,126 | $10.00 | $3.65M | $0 | 4 | 2020-12-01 |
| APRE | 10%+ Owner | 96,304 | $0.48 | $46.2K | $40.00M | 1 | 2019-10-09 |
| ARVN | Director | 1,775 | $7.43 | $13.2K | $0 | 3 | 2019-09-26 |
| scPharmaceuticals Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 1 | 2018-06-21 |
| BOLD | Director | — | $2.39 | — | $0 | 3 | 2018-06-08 |
Recent Filings · Page 6 of 6
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-20 | FIXX | Sell (S) | −525,900 | -$10.62M | EDGAR |
| 2018-06-21 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-08 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2018-04-04 | FIXX | Conv (C) | +5,392,037 | $0 | EDGAR |
| 2018-04-04 | FIXX | Conv (C) | +5,392,037 | $0 | EDGAR |
| 2018-03-29 | FIXX | Grant (A) | — | $0 | EDGAR |
| 2017-10-10 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2016-08-25 | BOLD | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.